(Q28276245)

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Physical growth: National Center for Health Statistics percentiles

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Survival of individuals with spinal muscular atrophy on ventilatory support

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Evaluation of pulmonary function in neuromuscular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Swallowing mechanism and neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Swallowing problems in neuromuscular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Craniofacial morphology of spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Masticatory muscle force and facial morphology in man

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Disturbance of swallowing after tracheostomy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Nutritional assessment in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

A new chart for weight control in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Weight reduction in boys with muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Creatine Supplementation Enhances Muscular Performance During High-Intensity Resistance Exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Impact of nutritional rehabilitation on gastroesophageal reflux in neurologically impaired children.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Incidence of gastroesophageal reflux with whey- and casein-based formulas in infants and in children with severe neurological impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021

Decrease in gastric emptying time and episodes of regurgitation in children with spastic quadriplegia fed a whey-based formula

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980026-0

7 January 2021